12:00 AM
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Fibrocaps: Completed Phase III enrollment

ProFibrix said it completed enrollment of 718 patients undergoing spinal, liver, vascular or soft tissue surgery in the single-blind, international Phase III FINISH-3 trial comparing Fibrocaps plus...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >